Literature DB >> 10423136

Covalent interactions are not required to permit or stabilize the non-covalent association of hepatitis C virus glycoproteins E1 and E2.

J Patel, A H Patel, J McLauchlan.   

Abstract

Hepatitis C virus (HCV) encodes two glycoproteins, E1 and E2, which are thought to locate to the envelope of virus particles. These proteins form two complexes in tissue culture systems, a high molecular mass aggregate that contains intermolecular covalent bonds and a native complex in which E1 and E2 associate by non-covalent interactions. The contribution of either complex to the structures of the proteins on virus particles is not known. Using dithiothreitol to reduce inter- and intramolecular disulphide bonds in situ, we have studied the nature of the interactions within the aggregate and the role of covalent bonds in the early stages of E1-E2 association. Results with two HCV type 1a strains, Glasgow and H77, showed that the aggregate contains not only covalent interactions but also non-covalent associations between E1 and E2. These non-covalent associations are complex since deletion mutant analysis failed to identify any single region which was required for non-covalent interaction. Complex formation by de novo synthesized proteins was not arrested under reducing conditions which prevented the production of inter- and intramolecular disulphide bonds. Moreover, a conformation-specific antibody continued to recognize the E2 protein in reduced complexes, indicating that covalent bonds do not stabilize certain structures of E2 that can interact with E1. These data suggest that disulphide bonds are not required either to allow association between the proteins or to stabilize E1-E2 complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423136     DOI: 10.1099/0022-1317-80-7-1681

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  No requirement of HCV 5'NCR for HCV-like particles assembly in insect cells.

Authors:  Wei Zhao; Guo-Yang Liao; Yan-Jun Jiang; Shu-De Jiang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  Phylogenetic analysis of previously nontypeable hepatitis C virus isolates from Argentina.

Authors:  María Inés Gismondi; Pablo Daniel Becker; Pamela Valva; Carlos Alberto Guzmán; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.

Authors:  Ayaz M Majid; Heather Ezelle; Sangeeta Shah; Glen N Barber
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles.

Authors:  Laurent Meertens; Claire Bertaux; Tatjana Dragic
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

5.  Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets.

Authors:  John McLauchlan; Marius K Lemberg; Graham Hope; Bruno Martoglio
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

6.  Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles.

Authors:  Reginald F Clayton; Ania Owsianka; Jim Aitken; Susan Graham; David Bhella; Arvind H Patel
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1.

Authors:  Julie Dumonceaux; Emmanuel G Cormier; Francis Kajumo; Gerald P Donovan; Jayanta Roy-Chowdhury; Ira J Fox; Jason P Gardner; Tatjana Dragic
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

8.  Endoplasmic Reticulum Detergent-Resistant Membranes Accommodate Hepatitis C Virus Proteins for Viral Assembly.

Authors:  Audrey Boyer; Julie Dreneau; Amélie Dumans; Julien Burlaud-Gaillard; Anne Bull-Maurer; Philippe Roingeard; Jean-Christophe Meunier
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.